+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Drug interactions with inhalational anaesthetics



Drug interactions with inhalational anaesthetics



Acta Anaesthesiologica Scandinavica 37(3): 231-244



The literature concerning the interactions between volatile anaesthetics, nitrous oxide and other compounds is reviewed. The majority are well known and most can be managed by careful dosage of the anaesthetics. The following interactions should be stressed since these are less predictable or potentially fatal. Of the cardiovascular drugs mainly the Ca++ channel blockers require attention. The volatile anaesthetics act synergistically with these drugs on the inhibition of cardiac conduction and may induce cardiac arrest. Aminoglycoside therapy should prompt an alternative to enflurane because of increased nephrotoxicity with this combination. Thiopentone induction makes the dog heart more susceptible to arrhythmias, especially during anaesthesia with volatile anaesthetics. Probably pentobarbitone, etomidate or a benzodiazepine should be preferred as an alternative to thiopentone when the use of adrenergic drugs peroperatively is anticipated. Nitrous oxide augments the sequelae after coronary air emboli and impaired cerebral perfusion in animals. The necessity of this drug should therefore be considered when anaesthetizing patients undergoing open heart surgery and patients with severe carotid or cerebral arteriosclerosis.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 031013688

Download citation: RISBibTeXText

PMID: 8517097

DOI: 10.1111/j.1399-6576.1993.tb03707.x


Related references

Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit. Best Practice & Research. Clinical Anaesthesiology 19(3): 523-538, 2005

The influence of inhalational anaesthetics on the oxidative drug metabolism in vitro and in vivo. Naunyn-Schmiedeberg's Archives of Pharmacology 287 Suppl: R79-R79, 1975

New inhalational anaesthetics. Anaesthesist 45(8): 674-693, 1996

Inhalational anaesthetics. 2012

Pharmacokinetics Of Inhalational Anaesthetics. Lancet 2(7351): 143-145, 1964

Inhalational anaesthetics and cardioprotection. Handbook of Experimental Pharmacology: 187-207, 2008

The newer inhalational anaesthetics. Practitioner 161(965): 361-371, 1948

Inhalational anaesthetics: an update. Acta Anaesthesiologica Belgica 47(1): 3-6, 1996

Halogenated inhalational anaesthetics. Best Practice & Research. Clinical Anaesthesiology 17(1): 29-46, 2003

Update on inhalational anaesthetics. Current Opinion in Anaesthesiology 22(4): 491-495, 2009

Occupational exposure to inhalational anaesthetics. Anaesthesia 52(7): 714-714, 1997

Biotransformation and toxicity of inhalational anaesthetics. Canadian Journal of Anaesthesia 37(4 Pt 2): Scxvi-Scxxiii, 1990

Clinical pharmacokinetics of the inhalational anaesthetics. Clinical Pharmacokinetics 12(3): 145-167, 1987

Chronic toxicity of inhalational anaesthetics. Annals of the Royal College of Surgeons of England 48(2): 79-79, 1971

Mechanisms of action of inhalational anaesthetics. South African Journal of Medical Sciences 41(4): 305-326, 1976